Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Immunome Inc

IMNM
Current price
9.91 USD -1.29 USD (-11.48%)
Last closed 11.59 USD
ISIN US45257U1088
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 808 460 544 USD
Yield for 12 month +24.91 %
1Y
3Y
5Y
10Y
15Y
IMNM
21.11.2021 - 28.11.2021

Immunome, Inc., a biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises AL102, an investigational gamma secretase inhibitor currently in evaluation in a Phase 3 trial for the treatment of desmoid tumors; and preclinical assets consist of IM-1021, a receptor tyrosine kinase-like orphan receptor 1 and antibody-drug conjugates, as well as IM-3050, a fibroblast activation protein targeted radioligand therapy; and IM-4320, an anti-IL-38 immunotherapy candidate. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington. Address: 18702 N. Creek Parkway, Bothell, WA, United States, 98011

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

32.25 USD

P/E ratio

Dividend Yield

Current Year

+14 018 000 USD

Last Year

+6 627 000 USD

Current Quarter

+2 364 000 USD

Last Quarter

+1 028 999 USD

Current Year

+13 290 000 USD

Last Year

-631 000 USD

Current Quarter

+1 691 000 USD

Last Quarter

+765 999 USD

Key Figures IMNM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -71 558 000 USD
Operating Margin TTM -1425.42 %
PE Ratio
Return On Assets TTM -26.85 %
PEG Ratio
Return On Equity TTM -199.56 %
Wall Street Target Price 32.25 USD
Revenue TTM 10 784 000 USD
Book Value 4.23 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -44.5 %
Dividend Yield
Gross Profit TTM
Earnings per share -7.54 USD
Diluted Eps TTM -7.54 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics IMNM

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IMNM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation IMNM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 49.414
Price Sales TTM 74.9685
Enterprise Value EBITDA -0.7158
Price Book MRQ 3.1849

Financials IMNM

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IMNM

For 52 weeks

6.93 USD 30.96 USD
50 Day MA 13.39 USD
Shares Short Prior Month 12 878 019
200 Day MA 16.34 USD
Short Ratio 12.78
Shares Short 10 924 384
Short Percent 19.24 %